Germany · Delayed Price · Currency is EUR SkinBioTherapeutics Statistics
Total Valuation
FRA:5KW has a market cap or net worth of EUR 50.04 million. The enterprise value is 49.80 million.
| Market Cap | 50.04M |
| Enterprise Value | 49.80M |
Important Dates
The next estimated earnings date is Tuesday, December 2, 2025.
| Earnings Date | Dec 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 258.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +19.79% |
| Shares Change (QoQ) | +13.96% |
| Owned by Insiders (%) | 19.89% |
| Owned by Institutions (%) | 67.98% |
| Float | 165.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.45 |
| PB Ratio | 9.22 |
| P/TBV Ratio | 175.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.99 |
| EV / Sales | 16.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.79 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.93 |
Financial Efficiency
Return on equity (ROE) is -63.28% and return on invested capital (ROIC) is -34.47%.
| Return on Equity (ROE) | -63.28% |
| Return on Assets (ROA) | -27.75% |
| Return on Invested Capital (ROIC) | -34.47% |
| Return on Capital Employed (ROCE) | -43.56% |
| Revenue Per Employee | 215,939 |
| Profits Per Employee | -207,608 |
| Employee Count | 15 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.71 |
Taxes
| Income Tax | -30,062 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.16% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.16% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 57.03 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:5KW had revenue of EUR 3.24 million and -3.11 million in losses. Loss per share was -0.01.
| Revenue | 3.24M |
| Gross Profit | 1.80M |
| Operating Income | -3.09M |
| Pretax Income | -3.14M |
| Net Income | -3.11M |
| EBITDA | -2.79M |
| EBIT | -3.09M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.50 million in cash and 1.24 million in debt, giving a net cash position of 254,538.
| Cash & Cash Equivalents | 1.50M |
| Total Debt | 1.24M |
| Net Cash | 254,538 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.43M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.37M |
Cash Flow
| Operating Cash Flow | -2.61M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 55.71%, with operating and profit margins of -95.36% and -96.14%.
| Gross Margin | 55.71% |
| Operating Margin | -95.36% |
| Pretax Margin | -97.07% |
| Profit Margin | -96.14% |
| EBITDA Margin | -86.20% |
| EBIT Margin | -95.36% |
| FCF Margin | n/a |
Dividends & Yields
FRA:5KW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.79% |
| Shareholder Yield | -19.79% |
| Earnings Yield | -6.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:5KW has an Altman Z-Score of 1.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 3 |